temoporfin has been researched along with Experimental Hepatoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Luo, FH; Quan, ZW; Shen, J; Shi, WB; Wang, JD; Yan, JH; Zhou, XP | 1 |
Dabkeviciene, D; Didziapetriene, J; Grazeliene, G; Juodka, B; Kirveliene, V; Kirvelis, D; Micke, I | 1 |
Molina, A; Rovers, JP; Saarnak, AE; Schuitmaker, JJ; Sterenborg, HJ; Terpstra, OT | 1 |
3 other study(ies) available for temoporfin and Experimental Hepatoma
Article | Year |
---|---|
Optimal treatment opportunity for mTHPC-mediated photodynamic therapy of liver cancer.
Topics: Animals; Carcinoma 256, Walker; Cell Line, Tumor; Half-Life; Injections, Intravenous; Liver Neoplasms, Experimental; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Wistar; Spectrometry, Fluorescence; Tissue Distribution | 2013 |
Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Administration Schedule; Female; Liver Neoplasms, Experimental; Male; Mesoporphyrins; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Xenograft Model Antitumor Assays | 2006 |
Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Topics: Animals; Antineoplastic Agents; Fluorescence; Liver Neoplasms, Experimental; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Rats | 1999 |